Psychiatry and Neurology, Neurology · Salt Lake City, UT
NPI
1457562233
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
370 E 9th Ave Ste 106
Salt Lake City, UT, 84103
Phone (801) 331-9660
Groups this clinician bills Medicare through
Medicare paid, 2024
$279K
39,577 services
Medicare patients, 2024
125
Average age 67
Drug cost, 2024
$404K
1,536 prescriptions
Company payments, 2025
$17K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stacey W Steeves was code J0585 (injection, onabotulinumtoxina, 1 unit), 36,000 times for 57 patients. In total Stacey W Steeves billed 39,577 services in 18 codes, and Medicare paid $279K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 36,000 | 57 | $4.75 | $171K |
| 64615 Musculoskeletal | Office | 183 | 57 | $103.78 | $19K |
| 99214 Office E&M - Established | Office | 137 | 87 | $81.72 | $11K |
By year: 2022 $534K for 51,805 services; 2023 $249K for 37,122 services; 2024 $279K for 39,577 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stacey W Steeves prescribed most often to Medicare patients was Aimovig Autoinjector (Erenumab-Aooe), with 189 prescriptions and refills. In total Stacey W Steeves wrote 1,536 Medicare prescriptions that cost $404K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aimovig Autoinjector Erenumab-Aooe | 189 | 222 | 28 | $162K |
| Topiramate Generic | 120 | 201 | 25 | $1,150 |
| Sumatriptan Succinate Generic | 96 | 108 | 19 | $13K |
| Rizatriptan Rizatriptan Benzoate | 93 | 113 | 25 | $2,280 |
| Ondansetron Odt Ondansetron | 84 | 89 | 29 | $1,257 |
| Gabapentin Generic | 80 | 108 | 12 | $2,045 |
| Quetiapine Fumarate Generic | 73 | 91 | 12 | $742 |
| Duloxetine Hcl Generic | 71 | 99 | 11 | $1,024 |
| Qulipta Atogepant | 68 | 70 | 13 | $79K |
| Pregabalin Generic | 52 | 52 | Under 11 | $276 |
| Prednisone Generic | 52 | 52 | 16 | $177 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 43 | 44 | Under 11 | $579 |
| Promethazine Hcl Generic | 37 | 39 | Under 11 | $898 |
| Cyclobenzaprine Hcl Generic | 37 | 37 | Under 11 | $156 |
| Emgality Pen Galcanezumab-Gnlm | 34 | 48 | Under 11 | $30K |
Brand drugs: 367 claims; generic drugs: 1,169 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacey W Steeves $17K ($17K in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $16K |
| TG Therapeutics, Inc. TGTX | 3 | $302 |
| Amgen Inc. AMGN | 3 | $77.06 |
| Biogen, Inc. BIIB | 3 | $76.95 |
| Genzyme Corporation SNY | 2 | $75 |
| CSL Behring CSL.AX | 2 | $63.8 |
| Genentech, Inc. ROG.SW | 2 | $51.85 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $48.59 |
| Genentech USA, Inc. ROG.SW | 3 | $48.03 |
| Lilly USA, LLC LLY | 3 | $47.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.